Command Palette

Search for a command to run...

AMBUJACEM
582.35(+0.23%)
1W: +2.36%

Financials

Charts

YoY Net Sales
Operating Margin
EPS Growth

Pros & Cons

POSITIVES
  • Significant revenue growth of 15.4% in the latest quarter compared to the previous one, reflecting strong market demand.
  • Net profit surged to ₹2620.09 Crore in Q4, indicating improved operational efficiency and cost management.
  • Operating profit margin increased to 10.51%, showcasing enhanced profitability despite fluctuating expenses.
NEGATIVES
  • Profit dropped sharply to ₹472.89 Crore in Q3, indicating volatility in earnings compared to prior quarters.
  • Material costs as a percentage of revenue are high, pressuring future profit margins.
  • Decline in other income, particularly from exceptional items, impacting overall profitability.

Quarterly Results Data

FieldTrendSep 23Dec 23Mar 24Jun 24Sep 24Dec 24Mar 25Jun 25
Revenue
7,423.958,128.808,893.998,311.487,516.119,328.569,888.6110,289.10
Expenses
6,564.286,884.547,741.317,566.917,023.498,347.688,821.709,256.69
Operating Profit
859.671,244.261,152.68744.57492.62980.881,066.911,032.41
Other Income
476.04193.65233.46354.72374.031,352.24573.26256.09
Interest
61.2570.1492.9167.8166.8566.9914.2967.14
Depreciation
380.90417.70453.06467.43551.96663.98786.35861.57
Profit Before Tax
1,339.711,448.121,601.141,102.68712.672,336.071,779.561,332.63
Tax
352.47358.5775.36313.05239.78-284.02497.32362.97
Net Profit
987.241,089.551,525.78789.63472.892,620.091,282.24969.66
Eps in Rs
3.994.145.312.671.858.593.883.20
Explore
Watchlists
Chat
Portfolio